Gene editing technology can effectively identify target molecules in parasites, and the use of classical transfection has allowed researchers to open new horizons in the study of gene-function relationships, while the introduction of CRISPR/Cas9 technology has played an important role in the study of parietal parasite genes, greatly improving the efficiency of gene editing and accelerating the progress of research on specific vaccines.
The continuous optimization and upgrading of the CRISPR/Cas9 system will better help scientists to understand parasites at the genetic level, so as to effectively combat parasitic diseases and safeguard human and animal health.
Ace Therapeutics specializes in parasitology and has established a parasite genetic engineering technology platform designed to provide genetic engineering services for a variety of parasitic diseases to clients worldwide. We can provide CRISPR/Cas9 gene editing services for Trypanosome, laying the foundation for in-depth elucidation of mechanistic studies.
We established a CRISPR/Cas9 genomic modification method for Trypanosome, which can efficiently perform gene knockout, gene plus tag and nucleotide substitution modifications in Trypanosome. Based on this, the method was further developed to address the technical needs of multiple gene modifications in the study of Trypanosome gene function. It provides a panoramic view to understand the regulation of gene expression in the life cycle of Trypanosome. If you want to know more, you are welcome to consult us.
We can provide CRISPR/Cas9 genomic modification services for different Trypanosome species, including but not limited to the following:
It successfully edited trypanosomes' genes and greatly shortened the experimental cycle, increased targeting loci, and extended the application of reverse genetics.
Applications
Delivery content: experiment report and Trypanosome or Trypanosome animal models that edited by CRISPR/Cas9 technology
Test fee: please get it through online inquiry.